Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CNDP1 encodes a member of the M20 metalloprotease family. Additionally we are shipping Carnosine Dipeptidase 1 (Metallopeptidase M20 Family) Proteins (14) and Carnosine Dipeptidase 1 (Metallopeptidase M20 Family) Kits (13) and many more products for this protein.
Showing 10 out of 89 products:
Human Polyclonal CNDP1 Primary Antibody for IHC, IHC (p) - ABIN4287941
Peters, Kebbewar, Jansen, Jakobs, Riedl, Koeppel, Frey, Adelmann, Klingbeil, Mack, Hoffmann, Janssen, Zschocke, Yard: Relevance of allosteric conformations and homocarnosine concentration on carnosinase activity. in Amino acids 2010
Show all 5 references for 4287941
Human Polyclonal CNDP1 Primary Antibody for EIA, FACS - ABIN951583
Craig, Millis, DiStefano: Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes. in Diabetic medicine : a journal of the British Diabetic Association 2009
Show all 2 references for 951583
Human Polyclonal CNDP1 Primary Antibody for ELISA - ABIN1995617
Riedl, Koeppel, Brinkkoetter, Sternik, Steinbeisser, Sauerhoefer, Janssen, van der Woude, Yard: A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7 transfected cells. in Diabetes 2007
Considering that approximately 40 per cent of the population are homozygous for the 5L allele of (CTG) n repeat polymorphism in CNDP1 gene and seem to be less prone to develop DN, it is needed to evaluate whether the majority of diabetic patients (who do not have the 5L-5L genotype) would be benefited from supplementation with carnosine or with a more intensive monitoring
Compared to healthy individuals and those with diabetes but no kidney disease, patients with diabetic nephropathy exhibited lower frequencies of 5L-5L genotype and 5L allele of CNDP1 gene, suggesting that this allele might confer protection against development of kidney disease in this population.
genetic association studies in pediatric population in Germany: Data suggest that, in pediatric patients with chronic kidney disease, the nephroprotective effect of CNDP1 Mannheim genetic variant against disease progression is not restricted to patients with diabetic nephropathy.
The experimentally measured higher affinity of homocarnosine for the enzyme relative to l-carnosine might be explained, at least in part, by more extensive interactions inside the monomeric and dimeric hCN1 (show HCN1 Antibodies)'s active site.
CNDP1 and CARNS are expressed in glomeruli and tubular cells; TauT (show TAUT Antibodies) is expressed in renal epithelial cells; CDNP1 may have a role in diabetic neuropathy
Data shows that higher carnosine content in human skeletal muscle is positively associated with insulin (show INS Antibodies) resistance and fasting metabolic preference for glucose.
In gastrointestinal cancer, reduced plasma levels of CNDP1 associate with signs of catabolism and poor outcome.
Alterations of serum carnosinase (CN1) activity has been associated with several pathological conditions, such as neurological disorders, chronic diseases and cancer
Rs12604675-A in CNDP1 may confer susceptibility to overt proteinuria in Japanese women with type 2 diabetes.
In this review, correlations between serum carnosine and carnosinase activity and polymorphism in CNDP1 gene are analyzed. The role of CNDP1 gene polymorphism the development of diabetic nephropathy and non-diabetic chronic kidney disease is discussed.
This gene encodes a member of the M20 metalloprotease family. The encoded protein is specifically expressed in the brain, is a homodimeric dipeptidase which was identified as human carnosinase. This gene contains trinucleotide (CTG) repeat length polymorphism in the coding region.
carnosine dipeptidase 1 (metallopeptidase M20 family)
, beta-Ala-His dipeptidase
, CNDP dipeptidase 1
, carnosinase 1
, glutamate carboxypeptidase-like protein 2
, serum carnosinase